Stay updated on XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check25 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check32 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check46 days agoChange DetectedThe page has removed a citation regarding the study of Cabozantinib in progressive medullary thyroid cancer, which is a significant change in the core content.SummaryDifference0.3%
Stay in the know with updates to XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page.